Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, placebo-controlled Phase 2 study of cariprazine adjunctive to antidepressant therapy in major depressive disorder
2011-005179-18Phase 2Completed
- Sponsor
- Forest Research Institute, Inc
- Start
- Dec 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing Cariprazine adjunctive arm with Placebo adjunctive arm (2 arms). Primary endpoint: Montgomery-Åsberg Depression Rating Scale. Started Dec 2011; status: completed.
02
Drugs
cariprazine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2011-005179-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005179-18.